LAPIMUN GEMІХ-3
combined vaccine against Rabbit Hemorrhagic Disease and Myxomatosis
Composition
The vaccine consists of two components with the same number of doses:
- an inactivated viruses of Rabbit Hemorrhagic Disease (in form of suspension)
strain BG-04 ≥ 640 HAU in one dose;
strain GBK-2 ≥ 640 HAU in one dose.
- a live vaccine virus of Rabbit Myxomatosis (freeze-dried)
strain “MAV/RK–13/20” ≥ 104,0 TCD50 in one dose.
Pharmaceutical form
Suspension and freeze-dried tablet.
Immunological properties
The vaccine protects rabbits against Hemorrhagic Disease and Myxomatosis for 8-10 months, and protective antibodies are formed in 7-14 days post-vaccination.
Target species
Rabbits.
Indications
Preventative immunization of rabbits against Hemorrhagic Disease (RHD) and Myxomatosis.
Interaction with other drugs
Do not mix with medicinal and prophylactic drugs including those against diseases of rabbits and components of other batches of the vaccine LAPIMUN GEMІХ-3 against Rabbit Hemorrhagic Disease and Myxomatosis of rabbits.
Special precautions (during gestation and lactation period)
To avoid abortions due to animals’ stresses it is not recommended to vaccinate females 7 days prior to the parturition.
Route of administration and dosage
After shaking, the vaccine component in suspension form is transferred using a syringe into the vial with the freeze-dried component. After dissolution, the vaccine is administered to clinically healthy rabbits starting from 28 days of age subcutaneously behind the shoulder blade at a dose of 1.0 ml with booster vaccination at the age of 4 months.
In the case of an early infection threat, all rabbits that are 28 days old and older are vaccinated regardless of the timeframe of the previous vaccination, with booster vaccination in three months with the vaccine LAPIMUN GEMІХ-3 or LAPIMUN MІХ – live vaccine against the rabbit myxomatosis.
Booster vaccination of rabbits is carried out every 8 months.
Vaccinated animals of the parent herd, with intensive use, are to be revaccinated at an interval of 6 months.
Withdrawalperiod
0days.
Shelf life
24 months. The vaccine should be used within 3 hours after dissolving.
Storage conditions
Store vaccine in dark places, out of the reach of children, at +2 to +8° С.
Presentation and packaging
Glassvials.